Patrick Horn

Insider Reports History

Entity
Individual
Location
C/O Tetraphase Pharmaceuticals, Inc., 480 Arsenal Street, Suite 110, Watertown, MA
Signature
/s/ Greg Tourangeau as attorney-in-fact for Patrick Horn
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Patrick Horn:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ALBIREO PHARMA, INC. Chief Medical Officer Common Stock 12.4K $541K $43.80 Oct 22, 2021 Direct
Fulcrum Therapeutics, Inc. Chief Medical Officer Stock Option (right to buy) 400K Mar 18, 2024 Direct
Fulcrum Therapeutics, Inc. Chief Medical Officer No securities are beneficially owned 0 Mar 18, 2024 Direct

Insider Reports Filed by Patrick Horn

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FULC Fulcrum Therapeutics, Inc. Mar 18, 2024 1 $0 4 Mar 20, 2024 Chief Medical Officer
FULC Fulcrum Therapeutics, Inc. Mar 18, 2024 0 $0 3 Mar 20, 2024 Chief Medical Officer
ALBO ALBIREO PHARMA, INC. Oct 22, 2021 1 -$2.74K 4 Oct 25, 2021 Chief Medical Officer
ALBO ALBIREO PHARMA, INC. Jul 22, 2021 1 -$3.07K 4 Jul 26, 2021 Chief Medical Officer